Application of Gene Expression Profiling Big Data in Anticancer Drug Discovery and Development

Authors

  • Zhihuan Fang
  • Xiangchen Li
  • Zixuan Zhou

DOI:

https://doi.org/10.61173/9s3xr331

Keywords:

Gene expression, big data, anticancer drugs

Abstract

As an important component of functional genomics, gene expression profiling plays an important role in many fields such as biology, medicine and drug development. Especially with the concept of precision medicine, integrating multi-omics data including gene expression profiles for personalized medicine is a future trend. From the background of anticancer drug development, the big data analysis method based on cellular perturbation expression profiling is introduced, and its application in anticancer covenant development is summarized. The findings suggest that continuous improvement of these methods will drive the discovery of novel biomarkers that can predict drug efficacy and toxicity, thereby accelerating the drug development process and improving patient prognosis. In the future, gene expression profiling is expected to be widely used in clinical practice, changing the landscape of cancer management and ushering in a new era of individualized cancer treatment that will achieve superior efficacy with fewer side effects than ever before.

References

[1] Guan Bo, Shan Weimin, Li Ming. Screening of potential therapeutic agents for bladder uroepithelial cancer based on gene Dean&Francis Zhihuan Fang Xiangchen Li, Zixuan Zhou expression profiling data[J]. Journal of Modern Genitourinary Oncology, 2023, 15(4): 203-207.

[2] Li Xiaotian, Wu Qifei, Zhang Dong. Screening of lung adenocarcinoma prognosis-associated genes based on a comprehensive gene expression database and the Cancer Genome Atlas database[J]. Cancer Progress, 2024, 22(7): 745- 753.

[3] Bow W.H., Sun H.Q., Shan Z.M., et al. Exploration of key genes and pathways in childhood pneumonia based on gene expression profiling[J]. Journal of Hebei Medical University, 2024, 45(5): 501-507.

[4] Han Xiaoling, Wang Shengchun, Han Prettyying, et al. Integration of multiple gene expression profiling data to identify key genes associated with osteosarcoma development and progression[J]. Journal of Guangdong Medical University, 2023, 41(6): 613-618.

[5] Lin Yaru, Yang Xi, Li Jinsong, et al. Analysis of SSBP1 gene expression and prognosis in hepatocellular carcinoma based on TCGA database[J]. Journal of Ningxia Medical University, 2024, 46(2): 146-152.

[6] Xiao Jingchuan, Zhang Yingai. Bioinformatics analysis of hepatocellular carcinoma genes based on expression profiling microarray data[J]. Journal of Central South University (Medical Edition), 2020, 45(9): 1053-1060.

[7] Chen Chao, Chen Tianxiang, Liu Qianwei, et al. Study of Hub genes in hepatocellular carcinoma analyzed and identified based on weighted gene co-expression network and cancer genome atlas clinical data[J]. Chinese Family Medicine, 2024, 27(32): 4050-4059.

[8] Yang Ning, Zhang Zhiqiang, Huang Feihu, et al. Modeling and evolutionary characterization of scientific data citation networks--an example of gene expression dataset[J]. Modern Intelligence, 2024, 44(5): 45-57.

[9] Chen Feng, Li Huainan, Zhang Xiaoyun, et al. Analysis of differential gene expression and immune cell infiltration in gout gene expression profile[J]. Chinese Journal of Immunology, 2024, 40(3): 592-598.

[10] Li Kunpeng, Wang Zepeng, Zhou Yu, et al. Research progress on the application of artificial intelligence in tumor gene expression data[J]. Chinese Journal of Medical Physics, 2024, 41(3): 389-396.

Downloads

Published

2025-06-26